Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Parallel, Single-Center, Double-Masked, Vehicle-Controlled Phase II Study to Evaluate the Activity of NS2 Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Provocation Test (CAPT)

Next Previous
Search
Trial Profile

A Randomized, Parallel, Single-Center, Double-Masked, Vehicle-Controlled Phase II Study to Evaluate the Activity of NS2 Ophthalmic Solution in Subjects With Allergic Conjunctivitis Using the Conjunctival Allergen Provocation Test (CAPT)

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 07 Dec 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Reproxalap (Primary)
  • Indications Allergic conjunctivitis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Aldeyra Therapeutics

    • Most Recent Events

    • 07 Nov 2016 Results from this trial will be presented at the 2016 American College of Allergy, Asthma and Immunology Annual Scientific Meeting
    • 03 Mar 2016 According to an Aldeyra Therapeutics media release, additional data from this trial will be presented at the Cowen and Company 36th Annual Health Care Conference.
    • 29 Feb 2016 Primary endpoint 'Mean change from baseline in Ocular tearing scores' has been met, according to an Aldeyra media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top